Nutlin-3a-loaded ethosomes as a delivery system in vitro to Target p53 in melanoma
Lodi, Giada; Voltan, Rebecca; Romani, Arianna; Casciano, Fabio; Bortolini, Olga; Ragno, Daniele; Esposito, Elisabetta; Benedusi, Mascia; Valacchi, Giuseppe; Secchiero, Paola; Zauli, Giorgio    
EARC, EARC Conference: Cellular Bases for Patient Response to Cancer Therapies
pp: 0-0, Anno: 2023

Ethosomes nanodelivery of the MDM2 inhibitor Nutlin-3a efficiently induces cells death in melanoma
Voltan, Rebecca; Romani, Arianna; Lodi, Giada; Casciano, Fabio; Bortolini, Olga; Ragno, Daniele; Esposito, Elisabetta; Benedusi, Mascia; Valacchi, Giuseppe; Secchiero, Paola; Zauli, Giorgio    
Firenze University Press, Italian Journal of Anatomy and Embryology- supplement
Vol. 127, No. 1, pp: 136-136, Anno: 2023

MDM2 inhibitors counteract inflammation by stabilization of ACE2 in vitro
Romani, Arianna; Lodi, Giada; Casciano, Fabio; Secchiero, Paola; Zauli, Giorgio; Voltan, Rebecca     dettagli >>
Firenze University Press, Italian Journal of Anatomy and Embryology- supplement
Vol. 127, No. 1, pp: 91-91, Anno: 2023

Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells
Lodi, Giada; Gentili, Valentina; Casciano, Fabio; Romani, Arianna; Zauli, Giorgio; Secchiero, Paola; Zauli, Enrico; Simioni, Carolina; Beltrami, Silvia; Fernandez, Mercedes; Rizzo, Roberta; Voltan, Rebecca     dettagli >>
PAGEPress, 95th National Congress of the Italian Society for Experimental Biology. Trieste, Italy, 12-15 April 2023
Vol. 96, No. Suppl 1, pp: 48-49, Anno: 2023

Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells
Lodi, Giada; Gentili, Valentina; Casciano, Fabio; Romani, Arianna; Zauli, Giorgio; Secchiero, Paola; Beltrami, Silvia; Fernandez, Mercedes; Rizzo, Roberta; Voltan, Rebecca     dettagli >>
Firenze University Press, Italian Journal of Anatomy and Embryology- supplement
Vol. 127, No. 1, pp: 240-240, Anno: 2023

Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL).
Cani, A.; Simioni, C.; Martelli, A. M.; Zauli, G.; Capitani, S.; Neri, L. M.     dettagli >>
AMER ASSOC CANCER RESEARCH, --
Vol. 21 Supplement: 17, No. 1, pp: 1-1, Anno: 2015

Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation.
Simioni, C; Cani, A; Martelli, Am; Zauli, G; Capitani, S; Neri, Lm     dettagli >>
AMER ASSOC CANCER RESEARCH, MOLECULAR CANCER THERAPEUTICS
Vol. 14 Supplement: S, No. 1, pp: 1-1, Anno: 2015

Studio dell’espressione e dell’attivita’ della proteina tat in linee cellulari ottenute da topi transegenici
Campioni, Diana; Corallini, A; Bolzonella, C; Lazzarin, L.; Zauli, Giorgio; Possati, L.; Barbanti Brodano, G.     dettagli >>
Pasquale Urbano,
Vol. 1, No. 1, pp: 28-28, Anno: 1994

Ruolo della proteina tat di hiv-1 in linee cellulari derivate da topi transgenici”
Corallini, A; Campioni, Diana; Altavilla, G; Possati, L.; Zauli, Giorgio; Sampaolesi, R; Barbanti Brodano, G.     dettagli >>
Associazione italiana contro AIDS, Atti VIII Convegno AIDS e sindromi correlate
Vol. 1, No. 1, pp: P5-P5, Anno: 1994